Pfizer’s COVID Booster Approved for Children Aged 5-11 in Japan

August 30, 2022
The Japanese health ministry on August 30 approved a label expansion for Pfizer/BioNTech’s COVID-19 vaccine for use as a booster, or a third shot, in children aged five through 11. Comirnaty intramuscular injection for ages 5 to 11 was initially...read more